Cargando…
Complete response in patient with liver metastasis of HER2-positive breast cancer following therapy with margetuximab: a case report
Metastatic human epidermal growth factor receptor 2 (HER2) positive breast cancer has a poor prognosis and few effective targeted therapies. However, several anti-HER2 agents are emerging in conjunction with chemotherapy, which may lead to increased rates of pathological complete response in patient...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344431/ https://www.ncbi.nlm.nih.gov/pubmed/36730303 http://dx.doi.org/10.1097/CAD.0000000000001466 |